Rosuvastatin prevents pressure overload-induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats

被引:16
|
作者
Xu, Xue [1 ]
Zhang, Lei [2 ]
Liang, Jiangjiu [1 ]
机构
[1] Shandong Univ, Dept Hlth Care, Shandong Prov Qianfoshan Hosp, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China
[2] Shandong Univ, Dept Orthoped, Shandong Prov Qianfoshan Hosp, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China
关键词
rosuvastatin; myocardial hypertrophy; pressure overload; Akt; extracellular signal-regulated kinase 1/2; GATA binding protein 4; INDUCED CARDIAC-HYPERTROPHY; LEFT-VENTRICULAR HYPERTROPHY; TRANSCRIPTION FACTOR GATA4; IN-VIVO; REGULATED KINASE; HEART-FAILURE; STRESS; ACTIVATION; REGRESSION; STATINS;
D O I
10.3892/mmr.2013.1548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pressure overload-induced myocardial hypertrophy is associated with a poor prognosis in humans and contributes to the development of cardiac arrhythmias, diastolic dysfunction and ultimate congestive heart failure. 3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors, also known as statins, have been previously shown to induce regression of myocardial hypertrophy in aortic banding models. However, there is limited knowledge regarding the underlying molecular mechanisms. Therefore, we hypothesized that the myocardial hypertrophy-related signaling pathways protein kinase B (Akt), extracellular signal-regulated kinases 1 or 2 (ERK1/2) and GATA binding protein 4 (GATA4) activation pathways constitute targets of rosuvastatin (RSV). Therefore, the above-mentioned activation pathways were hypothesized to be involved in the regression of pressure overload-induced myocardial hypertrophy treated by RSV. Twenty-eight Wistar rats were randomly allocated into 4 groups: the sham operation-vehicle (SH-V), abdominal aortic constriction-vehicle (AAC-V), abdominal aortic constriction-RSV 10 mg/kg/day (AAC-LO) and the abdominal aortic constriction-RSV 20 mg/kg/day (AAC-HI) group. Following the establishment of the abdominal aorta constriction model, we investigated the effect of RSV, a new hydrophilic statin, on abdominal aortic constriction-induced myocardial hypertrophy as well as the underlying intercellular signaling pathways after 5 days and 4 weeks of drug intervention. Moreover, echocardiographic features and the left ventricular weight to final body weight ratio (LVW/BW) were determined. Cross-sectional areas (CSAs) of cardiomyocytes were assessed by hematoxylin and eosin (H&E) staining. Atrial natriuretic factor (ANF), beta-myosin heavy chain (beta-MHC) and peroxisome proliferator-activated receptor alpha (PPAR alpha) messenger RNA (mRNA) expression was assessed using RT-PCR. The phosphorylation of Akt, ERK1/2 and GATA4 were also examined using western blot analysis. Our results showed that RSV significantly attenuates pressure overload-induced myocardial hypertrophy by preventing myocardial hypertrophy-related activation of Akt, ERK1/2 and GATA4 signaling pathways.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 50 条
  • [1] Changes of ERK1/2, PI3K-Akt Signaling Pathway in Pressure Overload-Induced Cardiac Hypertrophy in Mice
    Li Xiao-Mei
    Ma Yi-Tong
    Yang Yi-Ning
    Liu Fen
    Han Wei
    Zhang Jian-Fa
    Chen Bang-Dang
    Gao Xiao-Ming
    CIRCULATION, 2010, 122 (02) : E324 - E324
  • [2] Changes of ERK1/2, PI3K-Akt signaling pathway in pressure overload-Induced Cardiac Hypertrophy in Mice
    Li, X. M.
    Ma, Y.
    Yang, Y.
    Liu, F.
    Han, W.
    Chen, B. D.
    Zhang, J. F.
    Gao, X. M.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S122 - S122
  • [3] Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway
    Daryadel, Arezoo
    Bogdanova, Anna
    Gassmann, Max
    Mueller, Xavier
    Zuend, Gregor
    Seifert, Burkhardt
    Lehalle, Christine
    Frossard, Nelly
    Tavakoli, Reza
    JOURNAL OF CARDIOTHORACIC SURGERY, 2014, 9
  • [4] Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway
    Arezoo Daryadel
    Anna Bogdanova
    Max Gassmann
    Xavier Mueller
    Gregor Zünd
    Burkhardt Seifert
    Christine Lehalle
    Nelly Frossard
    Reza Tavakoli
    Journal of Cardiothoracic Surgery, 9
  • [5] Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice
    Yu, Juan
    Chen, Renshan
    Tan, Yafang
    Wu, Jiashin
    Qi, Jianyong
    Zhang, Minzhou
    Gu, Weiwang
    PLOS ONE, 2016, 11 (11):
  • [6] Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats
    Bhuiyan, Shenuarin
    Shioda, Norifumi
    Fukunaga, Kohji
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (06): : E1606 - E1614
  • [7] Gentisic acid attenuates pressure overload-induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway
    Sun, Simei
    Kee, Hae Jin
    Jin, Li
    Ryu, Yuhee
    Choi, Sin Young
    Kim, Gwi Ran
    Jeong, Myung Ho
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (12) : 5964 - 5977
  • [8] Impacts of a Specific Cyclooxygenase-2 Inhibitor on Pressure Overload-Induced Myocardial Hypertrophy in Rats
    Xie, Zhixiang
    Wang, Shuyin
    Liang, Zijing
    Zeng, Liangbo
    Lai, Rongde
    Ye, Zheng
    Liao, Pinhu
    HEART SURGERY FORUM, 2019, 22 (06): : E432 - E437
  • [9] Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload
    Qi, Jianyong
    Liu, Qin
    Gong, Kaizheng
    Yu, Juan
    Wang, Lei
    Guo, Liheng
    Zhou, Miao
    Wu, Jiashin
    Zhang, Minzhou
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [10] Stimulation of Akt/eNOS signaling through Sigma-1 receptor ameliorates pressure overload-induced cardiac hypertrophy in ovariectomized rats
    Fukunaga, Kohji
    Shioda, Norifumi
    Tagashira, Hideaki
    Bhuiyan, Shenuarin Md
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2010, 22 : S59 - S59